Archives

img-01

Outsourcing Medical Products to Asia

As competition in the global medical device market intensifies, U.S. medical companies are increasingly seeking out ways to reduce costs in manufacturing, R&D, clinical trials and other medical services. Many Asian countries offer a lower cost of labor (China and India) and... Read More

img-01

India to Pass Amendment for Pharmaceutical Patents

India’s Parliament is expected to pass the long-awaited Third Patent Amendment Bill in January 2005, providing for more transparency and security in India’s six billion dollar pharmaceutical industry, comprised of around 20,000 foreign and domestic drug makers. The Third Amendment Bill will... Read More

img-01

India to Amend Clinical Trial Regulations

Many companies look to India for clinical trials, as the country offers a large, diverse population and varied gene pool. Therefore, patient recruitment is often an easier and faster process in India than in the West and companies can save as much... Read More